Dr. Robinson Reveals 340B Programs’ Effect on Drug Pricing
TL/DR -
A study published in The New England Journal of Medicine analyzed how insurer drug expenditures on infused drugs affected price markups in hospitals. The research revealed that the 340B drug pricing program, initially designed to provide medications to low-income patients, has become a significant revenue stream for hospitals. The study…